Literature DB >> 21131042

Zoledronic acid in myeloma: MRC Myeloma IX.

S Vincent Rajkumar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131042     DOI: 10.1016/S0140-6736(10)62178-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Authors:  Rahul Mhaskar; Ambuj Kumar; Branko Miladinovic; Benjamin Djulbegovic
Journal:  Cochrane Database Syst Rev       Date:  2017-12-18

Review 2.  The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.

Authors:  Paul G Richardson; Jacob P Laubach; Robert L Schlossman; Irene M Ghobrial; Constantine S Mitsiades; Jacalyn Rosenblatt; Anuj Mahindra; Noopur Raje; Nikhil Munshi; Kenneth C Anderson
Journal:  Eur J Haematol       Date:  2011-11-22       Impact factor: 2.997

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.